JanOne Files International Patent Application For Methods Of Using Low Dose Naltrexone To Treat Chronic Pain
Portfolio Pulse from Benzinga Newsdesk
JanOne Inc. has filed an international patent application for methods of using low dose Naltrexone to treat chronic pain.

June 28, 2023 | 12:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JanOne's filing of an international patent application for methods of using low dose Naltrexone to treat chronic pain could potentially open new markets and revenue streams for the company.
The filing of an international patent application indicates that JanOne is looking to protect its intellectual property rights on a global scale. This could potentially open up new markets for the company, leading to increased revenues. However, the impact on the stock price will depend on the success of the patent application and the subsequent commercialization of the product.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100